BioLife Solutions Inc
NASDAQ:BLFS

Watchlist Manager
BioLife Solutions Inc Logo
BioLife Solutions Inc
NASDAQ:BLFS
Watchlist
Price: 27.39 USD 4.9% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
BioLife Solutions Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one BLFS stock under the Base Case scenario is 12.07 USD. Compared to the current market price of 27.39 USD, BioLife Solutions Inc is Overvalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLFS Relative Value
Base Case
12.07 USD
Overvaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

10.7
P/S
P/S
Price to Sales
10.7
vs History
50
vs Industry
19
Median 3Y
6.1
Median 5Y
8.9
Industry
2.3
Forward
11.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
1
Median 3Y
-11.1
Median 5Y
-10.5
Industry
23.1
Forward
-30.6
More Details
139.2
P/OCF
P/OCF
Price to OCF
139.2
vs History
33
vs Industry
4
Median 3Y
-69.7
Median 5Y
-57.3
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-56.8
Median 5Y
-77.6
Industry
20.1
More Details
3.9
P/B
P/B
Price to Book Value
3.9
vs History
49
vs Industry
30
Median 3Y
2.5
Median 5Y
3.2
Industry
2.2
More Details
10.6
EV/S
EV/S
Enterprise Value to Sales
10.6
vs History
49
vs Industry
18
Median 3Y
6.1
Median 5Y
8.8
Industry
2.4
Forward
11.3
More Details
22.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
22.9
vs History
55
vs Industry
8
Median 3Y
18.8
Median 5Y
19
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
0
Median 3Y
-34.5
Median 5Y
-19.8
Industry
12.7
Forward
86.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-22.3
Median 5Y
-17.1
Industry
17.1
Forward
-79.3
More Details
137.5
EV/OCF
EV/OCF
Enterprise Value to OCF
137.5
vs History
33
vs Industry
5
Median 3Y
-67.9
Median 5Y
-56.6
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-41
Median 5Y
-49.2
Industry
18
More Details
3.5
EV/IC
EV/IC
Enterprise Value to IC
3.5
vs History
49
vs Industry
31
Median 3Y
2.2
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

BLFS Competitors Multiples
BioLife Solutions Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
BioLife Solutions Inc
NASDAQ:BLFS
1.3B USD 10.7 -27.5 -101.4 -57.7
JP
Hoya Corp
TSE:7741
6.8T JPY 8.6 35.8 23.7 28.7
CH
Alcon AG
SIX:ALC
37.6B CHF 4.3 36.3 17.8 34.5
DK
Coloplast A/S
CSE:COLO B
179.6B DKK 6.6 35.6 22.9 26.9
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD 4 35.7 18 21.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.4B CNY 11.6 27.8 24.1 24.1
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.4 -17.2 16.7 55.8
KR
HLB Inc
KOSDAQ:028300
9.1T KRW 175.4 -49 -75.4 -71.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD 4.1 14.5 10 11.3
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.2 264.5 462.1
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.7 23.8 39
P/E Multiple
Earnings Growth P/E to Growth
US
BioLife Solutions Inc
NASDAQ:BLFS
Average P/E: 33.8
Negative Multiple: -27.5 		N/A N/A
JP
Hoya Corp
TSE:7741
35.8
52%
0.7
CH
Alcon AG
SIX:ALC
36.3
107%
0.3
DK
Coloplast A/S
CSE:COLO B
35.6
50%
0.7
US
Align Technology Inc
NASDAQ:ALGN
35.7
102%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.8
92%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.2 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -49 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.5
69%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
37.2
208%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.7
159%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
BioLife Solutions Inc
NASDAQ:BLFS
Average EV/EBITDA: 46.8
Negative Multiple: -101.4 		N/A N/A
JP
Hoya Corp
TSE:7741
23.7
51%
0.5
CH
Alcon AG
SIX:ALC
17.8
34%
0.5
DK
Coloplast A/S
CSE:COLO B
22.9
39%
0.6
US
Align Technology Inc
NASDAQ:ALGN
18
52%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
103%
0.2
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
82%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -75.4 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10
43%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
264.5
42%
6.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.8
81%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
BioLife Solutions Inc
NASDAQ:BLFS
Average EV/EBIT: 78.2
Negative Multiple: -57.7 		N/A N/A
JP
Hoya Corp
TSE:7741
28.7
N/A N/A
CH
Alcon AG
SIX:ALC
34.5
107%
0.3
DK
Coloplast A/S
CSE:COLO B
26.9
42%
0.6
US
Align Technology Inc
NASDAQ:ALGN
21.7
58%
0.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.1
87%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
55.8
283%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -71.1 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.3
47%
0.2
UK
ConvaTec Group PLC
LSE:CTEC
462.1
96%
4.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
39
148%
0.3

See Also

Summary
BLFS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLFS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLFS stock valuation using valuation multiples.
Wall Street Estimates
BLFS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLFS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.